Semaglutide 3mg
$100.00
Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist investigated for its effects on glucose metabolism, appetite regulation, and metabolic pathways in research models. Studied for its interactions with incretin hormone receptors, gastric emptying mechanisms, and insulin sensitivity markers. Research applications include metabolic syndrome, type 2 diabetes, and obesity research models. 3mg per tablet, 50 count oral formulation. ≥98% purity, HPLC-tested. ⚠️ FOR RESEARCH USE ONLY — NOT FOR HUMAN CONSUMPTION. This product has not been evaluated by the FDA. Sold exclusively for in vitro laboratory research by qualified professionals.
Research & Studies
Research Use Only
For in vitro laboratory research use only. Not for human consumption, medical use, or self-administration. Not evaluated by the FDA. Purchaser confirms they are a qualified researcher and assumes all responsibility for compliance with applicable federal, state, and local laws. This compound may be regulated as a controlled substance or prescription drug in certain jurisdictions.
In Vitro Research Protocol Reference
Research Concentration
0.25–2.4 mg
Frequency
Once weekly
Administration
Subcutaneous injection
Published research references gradual concentration escalation protocols over 4-week intervals.
Semaglutide 3mg
$100.00
Frequently Bought Together
CJC-1295 + Ipamorelin 10mg
$45.00
Epithalon 10mg
$35.00
AOD9604 5mg
$35.00